bioRxivMicrobiologyPreprint
Sex-biased response to and brain cell infection by SARS-CoV-2 in a highly susceptible human ACE2 transgenic model
C.-Y. Tsai, Y.-C. Chou, C.-Y. Chen, J.-T. Jan, M.-L. Chang, L.-A. Lu, P.-Y. Huang, M. F.- C. Chu, T.-T. Hsu, Y.-P. Hsueh
Abstract
The COVID-19 pandemic is caused by SARS-CoV-2 infection. Human angiotensin-converting enzyme II (hACE2) has been identified as the receptor enabling SARS-CoV-2 host entry. To establish a mouse model for COVID-19, we generated transgenic mouse lines using the (HS4)2-pCAG-hACE2-HA-(HS4)2 transgene cassette, which expresses HA-tagged hACE2 under control of the CAG promoter and is flanked by HS4 insulators. Expression levels of the hACE2 transgene are respectively higher in lung, brain and kidney of our CAG-hACE2 transgenic mice and relatively lower in duodenum, heart and liver. The CAG-hACE2 mice are highly susceptibility to SARS-CoV-2 infection, with 100 PFU of SARS-CoV-2 being sufficient to induce 87.5% mortality at 9 days post-infection and resulting in a sole (female) survivor. Mortality was 100% at the higher titer of 1000 PFU. At lower viral titers, we also found that female mice exposed to SARS-CoV-2 infection suffered much less weight loss than male mice, implying sex-biased responses to SARS-CoV-2 infection. We subjected neuronal cultures to SARS-CoV-2 pseudovirus infection to ascertain the susceptibilities of neurons and astrocytes. Moreover, we observed that expression of SARS-CoV-2 Spike protein alters the synaptic responses of cultured neurons. Our transgenic mice may serve as a model for severe COVID-19 and sex-biased responses to SARS-CoV-2 infection, aiding in the development of vaccines and therapeutic treatments for this disease.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of low copy number human angiotensin-convertase 2 (hACE2)-transgenic mice as an improved model of SARS-CoV-2 infection
C. M. Bradshaw, T. Georgieva, … J. Z. Nikolich·bioRxiv·Aug 31, 2023
- Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression
M. Carossino, P. Montanaro, … N. Crossland·bioRxiv·Jan 13, 2021
- Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Joseph W. Golden, Curtis R. Cline, … Jay W. Hooper·bioRxiv·Jul 9, 2020
- A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.
Anna Pons-Grífols, Ferran Tarrés-Freixas, … Julià Blanco·mBioPeer-reviewed·Apr 24, 2025
- Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice
F. Oladunni, J.-G. Park, … J. B. Torrelles·bioRxiv·Jul 18, 2020
- Evaluation of K18-hACE2 mice as a model of SARS-CoV-2 infection
G. B. Moreau, S. L. Burgess, … B. J. Mann·bioRxiv·Jun 26, 2020